Global Veterinary Intelligence
Reader login
Veterinary33

Free reader access

Every article remains open. Registration is for participation, not access.

Create a profile to comment, join discussions, receive more relevant recommendations, keep your activity connected, and access selected opportunities.

Article · Clinical Study · 2 min read

N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease a double-blind, placebo-controlled clinical trial.

Clinical evidence update from BMC veterinary research

July 28, 2026 at 12:00 PM UTCBMC veterinary researchVeterinary33 Editorial Desk

Comments on this article are also part of the Veterinary33 clinical forum.

N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease a double-blind, placebo-controlled clinical trial.

Share this article

Share the exact article page with colleagues or your professional network.

LinkedInEmail

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in BMC veterinary research in 2026 evaluated n-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease: a double-blind, placebo-controlled clinical trial..

Key Findings

Oxidative stress is considered a significant contributing factor of chronic kidney disease (CKD). To date, there is a paucity of clinical data in the literature regarding the effect of N-Acetylcysteine (NAC) in cats with naturally developing CKD. The aim of the study is to evaluate whether the addition of NAC in the treatment of cats with acute exacerbations of CKD could improve kidney function biomarkers over the use of intravenous fluid therapy alone. A total of 50 client-owned cats were included in the study. The inclusion criteria comprised cats previously diagnosed with azotemic CKD (IRIS stage 2-4) in addition to ultrasonographic...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Discussion thread

Community replies

1 reply

Editorial connection
Reviewed
Reader avatar: French bulldog puppy
Dr. Elena Marlowe
Veterinary33 Editorial CuratorSmall Animal and Feline MedicineEditorially reviewed

The study examines the role of N-acetylcysteine in managing biomarkers associated with chronic kidney disease in feline patients. Both this research and the book Point of Care Ultrasound in Dogs and Cats by Roberto Rabozzi and Stefano Oricco address point-of-care ultrasound as a clinical diagnostic tool in feline patients. Related coverage appears in Point of Care Ultrasound in Dogs and Cats by Roberto Rabozzi and Stefano Oricco.

Continue exploring

Point of Care Ultrasound in Dogs and Cats

By Roberto Rabozzi and Stefano Oricco

Point-of-care ultrasound as a clinical diagnostic tool in feline patientscatsfelinefluid

Explore the book for additional coverage of the related themes discussed in this article.

View the book
Open full thread

Join this discussion

Add your reply

Share a professional insight, ask a focused question, or add relevant clinical experience.

1 reply below

Member participation

Log in to join the discussion

Share an answer, ask a question, reply to another professional, or mark useful contributions as helpful.

Log in to reply

Continue the conversation

Share this article with another veterinary professional.

LinkedInEmail
Articles remain free

Create a profile when you are ready to participate.

Veterinary33 does not require registration to read its articles. A free reader profile connects your discussions, recommendations, professional details, and reader activity.

After registration or login, you will return to this exact article.

Registered readers may also receive selected educational and community opportunities.

Join discussions

Comment on articles and participate in professional conversations.

Relevant recommendations

Use your reading and engagement activity to surface more useful articles.

Connected reader activity

Return to your likes, comments, discussions, and article activity in one place.

Professional profile

Add your profession, specialty, workplace, biography, and profile image.

Registration is optional

Continue reading